Answers are grounded in this paper and cite their sources.
Introduction : Burning mouth syndrome is a chronic oral pain condition with limited effective treatments. Cannabidiol has emerged as a potential therapeutic option, but clinical evidence remains limited. This study evaluated the efficacy and safety of full spectrum cannabidiol oil. Methods : A randomized, placebo-controlled clinical trial was conducted in a single-center outpatient clinic for orofacial pain. Thirty-five individuals were screened, and 26 patients were included and randomly assigned to receive cannabidiol oil (n = 13) or placebo (n = 13). Pain intensity and impact were assessed using a visual analogue scale, and oral health–related quality of life was evaluated using the Oral Health Impact Profile-14. Safety outcomes included adverse event monitoring. Results : The sample comprised 96% women, with a mean age of 61.9 years. Baseline measures were comparable. The cannabidiol group showed significant reductions in pain intensity and impact over time, with between-group differences from the third assessment onward (P < .001), while the placebo group remained stable. Quality of life improved significantly in the cannabidiol group (P = .001). No serious adverse events were observed. Conclusions : Full spectrum cannabidiol oil improved pain and quality of life with a favorable safety profile, supporting further investigation .
No takes yet. Share an insight, caveat, or question.
Parise et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: